Go
Contact Us
Small
Medium
Large
Text Size
Home
Company
Management
Board of Directors
Corporate Governance
Collaborators
Technology Licenses
Ethics and Compliance
History
Social Responsibility
Locations
Contact
Products
ARCALYST
®
(rilonacept)
EYLEA™ (aflibercept) Injection
Pipeline
Inflammation
Metabolism
Oncology
Ophthalmology
Pain
Science
Scientific Leadership
Therapeutic Focus Areas
Target Discovery
Drug Candidate Platforms
Protein Production
Publications
Investors
Media
Press Releases
Events and Presentations
Financial Information
Stock Information
Corporate Governance
Investor FAQs
Investor Contact
Careers
Working at Regeneron
Our Organization
Benefits
Search Jobs
Investors
Printed Materials
Email
Print
Investors
Media
Press Releases
Contact Media Relations
E-Press Kit
Image Gallery
Press Releases
Events and Presentations
SEC Filings
Financial Information
Annual Reports and Proxy Statements
Quarterly Reports
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calendar
Analyst Coverage
Analyst Estimates
Ownership Profile
Corporate Governance
Committee Composition
Contact the Board
Insider Transactions
Investor FAQs
Investor Contact
Featured Report
2010
Annual Report and 10K
2011
Proxy Statement
Shareholder Tools
Shareholder Briefcase
E-mail Alerts
Download Library
REGN Snapshot
RSS News Feeds
To receive printed material by postal mail, please complete the following form.
*
Required fields
Please send me
*
Document
Request
Investor Kit
2008 Annual Report & 10-K
First name
*
Last name
*
Email
*
Title
Company
Profile
*
Please Select
Individual Investor
Equity Analyst (sell-side)
Equity Analyst (buy-side)
Fixed Income Analyst (sell-side)
Fixed Income Analyst (buy-side)
Portfolio Manager (Equity)
Portfolio Manager (Fixed Income)
Broker/Investment Advisor
Banker/Financing Source
Press/Media
Consultant
Employee
Customer/Client
Library/Reference
Student
Other
Address
*
City
*
State/province
*
Postal code
*
Country
*
Shipment method
Postal Mail
DHL
Federal Express
Federal Express Priority
UPS Next Day Air
Account number
Required for express delivery
Telephone
Home
Fax
Work
Extension
Type in number
*
This helps Regeneron Pharmaceuticals, Inc. prevent automated submissions.
I am interested in receiving investor relations notifications. **
** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.
Close Video
Close Window
Form content here please :)